诺氟沙星治疗单纯性淋病。
Norfloxacin in the therapy of uncomplicated gonorrhea.
作者信息
Romanowski B, Wood H, Draker J, Tsianco M C
出版信息
Antimicrob Agents Chemother. 1986 Sep;30(3):514-5. doi: 10.1128/AAC.30.3.514.
Abstract
In an open study, 70 patients with uncomplicated anogenital Neisseria gonorrhoeae infection were evaluated to determine the efficacy and safety of a single oral dose of norfloxacin (800 mg). Norfloxacin cured all 31 male urethral and 25 endocervical infections. All 63 isolates of N. gonorrhoeae tested were inhibited by 0.05 microgram of norfloxacin per ml.
摘要
在一项开放性研究中，对70例无并发症的肛门生殖器淋病奈瑟菌感染患者进行了评估，以确定单次口服800毫克诺氟沙星的疗效和安全性。诺氟沙星治愈了所有31例男性尿道感染和25例宫颈感染。所检测的全部63株淋病奈瑟菌均被每毫升0.05微克的诺氟沙星抑制。
相似文献
1
Norfloxacin in the therapy of uncomplicated gonorrhea.诺氟沙星治疗单纯性淋病。
Antimicrob Agents Chemother. 1986 Sep;30(3):514-5. doi: 10.1128/AAC.30.3.514.
2
Clinical trial of norfloxacin in the treatment of uncomplicated gonococcal urethritis: preliminary report.诺氟沙星治疗单纯性淋菌性尿道炎的临床试验：初步报告。
Drugs Exp Clin Res. 1989;15(1):33-5.
3
Norfloxacin in the therapy of gonococcal infections.诺氟沙星在淋病感染治疗中的应用。
Scand J Infect Dis Suppl. 1986;48:40-5.
4
Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in Rwanda.诺氟沙星与甲砜霉素治疗卢旺达单纯性淋病的疗效比较
Antimicrob Agents Chemother. 1987 Mar;31(3):434-7. doi: 10.1128/AAC.31.3.434.
5
Norfloxacin in the treatment of uncomplicated gonorrhoeae in nonpregnant females.诺氟沙星治疗非妊娠女性单纯性淋病
J Med Assoc Thai. 1987 Mar;70(3):121-6.
6
Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.口服诺氟沙星治疗耐青霉素淋病奈瑟菌
N Engl J Med. 1984 Jul 19;311(3):137-40. doi: 10.1056/NEJM198407193110301.
7
[Bacteriological and clinical evaluation of norfloxacin in male gonorrheal urethritis].诺氟沙星治疗男性淋菌性尿道炎的细菌学及临床评估
Hinyokika Kiyo. 1987 Jun;33(6):968-71.
8
Antimicrobial susceptibility and plasmid profile of Neisseria gonorrhoeae in India (New Delhi).印度（新德里）淋病奈瑟菌的抗菌药敏性及质粒图谱
Sex Transm Infect. 1998 Jun;74(3):210-2. doi: 10.1136/sti.74.3.210.
9
Rosoxacin in the therapy of uncomplicated gonorrhea.罗索沙星治疗单纯性淋病
Antimicrob Agents Chemother. 1984 Apr;25(4):455-7. doi: 10.1128/AAC.25.4.455.
10
Norfloxacin in the treatment of gonorrhea due to penicillinase and non-penicillinase producing Neisseria gonorrheae: a review.诺氟沙星治疗产青霉素酶和不产青霉素酶淋病奈瑟菌所致淋病的综述。
Scand J Infect Dis Suppl. 1988;56:49-54.
引用本文的文献
1
A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned.淋病诊断和治疗的演进简史：经验教训。
Clin Infect Dis. 2018 Sep 28;67(8):1294-1299. doi: 10.1093/cid/ciy271.
2
Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.由于携带GyrA突变的喹诺酮耐药菌株普遍存在，帕珠沙星治疗淋病的临床疗效降低。帕珠沙星性传播疾病研究组。
Antimicrob Agents Chemother. 1998 Mar;42(3):579-82. doi: 10.1128/AAC.42.3.579.
3
Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.采用琼脂稀释法测定生殖支原体对新型喹诺酮类药物的敏感性。
Antimicrob Agents Chemother. 1989 Jan;33(1):103-7. doi: 10.1128/AAC.33.1.103.
4
Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.氟喹诺酮类药物治疗泌尿生殖道感染：生殖器感染的临床疗效及不良反应
Antimicrob Agents Chemother. 1989 Oct;33(10):1662-7. doi: 10.1128/AAC.33.10.1662.
5
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
本文引用的文献
1
Evaluation of the Phadebact Gonococcus Test for confirmation of Neisseria gonorrhoeae.用于确认淋病奈瑟菌的法德巴克淋球菌检测评估。
J Clin Microbiol. 1980 Jul;12(1):15-7. doi: 10.1128/jcm.12.1.15-17.1980.
2
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.Mk-0366与其他选定口服抗菌剂对淋病奈瑟菌的体外活性比较
Antimicrob Agents Chemother. 1981 Aug;20(2):265-6. doi: 10.1128/AAC.20.2.265.
3
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.壮观霉素类似物U-63366及四种喹诺酮衍生物对淋病奈瑟菌的体外活性
Antimicrob Agents Chemother. 1984 Oct;26(4):608-9. doi: 10.1128/AAC.26.4.608.
4
Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.口服诺氟沙星治疗耐青霉素淋病奈瑟菌
N Engl J Med. 1984 Jul 19;311(3):137-40. doi: 10.1056/NEJM198407193110301.
5
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.环丙沙星、诺氟沙星、吡哌酸、西诺沙星和萘啶酸对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1984 Jan;25(1):123-4. doi: 10.1128/AAC.25.1.123.
6
Norfloxacin disposition after sequentially increasing oral doses.依次增加口服剂量后诺氟沙星的处置情况。
Antimicrob Agents Chemother. 1983 Feb;23(2):284-8. doi: 10.1128/AAC.23.2.284.
7
Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.诺氟沙星与选定抗菌药物对尿路病原体和淋病奈瑟菌的体外活性比较
J Antimicrob Chemother. 1982 Dec;10(6):553-7. doi: 10.1093/jac/10.6.553.
8
Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure.单剂量甲烯土霉素和强力霉素治疗淋病：治疗失败频率及原因的合作研究
J Infect Dis. 1973 Apr;127(4):461-6. doi: 10.1093/infdis/127.4.461.
9
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.氟喹诺酮类药物：结构、作用机制与耐药性以及体外活性谱
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6. doi: 10.1128/AAC.28.4.581.
10
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.氟喹诺酮类药物：人体药理学、临床应用及毒性
Antimicrob Agents Chemother. 1985 Nov;28(5):716-21. doi: 10.1128/AAC.28.5.716.
Zotero 插件